Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team
Regulatory press release

SensoDetect AB: SensoDetect advances Middle East expansion - introduces strategy for private school screening programs and SensoDetect-owned screening centers

SensoDetect
Read the release

SensoDetect AB (publ) announces the next phase of its previously communicated expansion in the Middle East. Last week, representatives of SensoDetect visited the region to continue discussions with private school groups, healthcare providers, and regional partners.

The delegation consisted of

- Dr. Mohamed Hussein Atwa Ahmed, Global Head of Clinical Research

- Ahmad Alosta, Regional Business Development and Quality Assurance (QA)

- Maher Almajzoub, External Partner in Business Development in the MENA region 

The updated market strategy consists of two complementary commercial models

1. Private School Screening Programs (B2B)

SensoDetect will offer standardized neuro-auditory screening using the SensoDetect BERA platform directly to private school networks. The screening supports early identification of neurodevelopmental conditions and provides structured documentation for follow-up clinical evaluation when needed.

2. SensoDetect-Owned Screening Centers (Direct Access)

The company intends to establish SensoDetect-owned screening centers in selected cities. These centers will serve as regional hubs where families, clinics, and hospitals can access standardized screening and referral support under unified clinical and operational protocols.

"We see a clear and growing interest in early and structured screening in the region," said PA Hedin, CEO of SensoDetect AB. "Last week's visit provided a strong foundation for concrete next steps. Combining school-based programs with our own centers provides both accessibility and long-term presence."

The ongoing autism study led by Dr. Fatimah continues according to plan. Upcoming data is expected to support continued development of screening and referral workflows in the region.

"There is strong commitment to objective evaluation at an early stage," said Dr. Mohamed Hussein Atwa Ahmed, Global Head of Clinical Research, SensoDetect. "The SensoDetect BERA method aligns well with current initiatives in both the education and healthcare sectors."

"For many families, understanding their child's behavior can be confusing and stressful. The SensoDetect test brings clarity and hope; it helps parents see their child's challenges in a new light and opens the door to early support," said Mrs. Neven Ahmad, Journalist at Al-Thaerah Journal.

"Our discussions with school networks showed a strong openness to integrating structured screening as part of student health programs," said Ahmad Alosta, Regional Business Development and Quality Assurance (QA). "This creates a clear pathway for scalable implementation in the private education sector."

"Local coordination and continuity are essential for establishing trust and long-term adoption," said Maher Almajzoub, External Partner in Business Development in the MENA region. "Our presence on the ground ensures that implementation will be practical, culturally aligned, and sustainable."

SensoDetect will provide further updates as agreements are finalized, and implementation activities begin. Photos from the visit and school-based screening activities are attached to this release.

Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.